Meeting: 2018 ASCO Annual Meeting Track: Genitourinary (Nonprostate) Cancer Abstract number: 4503 Authors: Arlene O. Siefker-Radtke, Andrea Necchi, Se Hoon Park, et. al. Background: ERDA is an FGFR inhibitor with activity in pts with mUC and FGFRalt. FGFRalt occur in 10-20% of mUC and are enriched in immunologically “cold” luminal 1...
Pro zobrazení tohoto obsahu je třeba být přihlášen.